CARA HUEBNER: Open Payments
NPI 1184241200 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 64 payments from 18 companies in 2025. Trend: 2023 $891 · 2024 $764 · 2025 $1,033
Food & beverage: $1,008Consulting: $25
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $247 |
| PFIZER INC. | 8 | $137 |
| Lilly USA, LLC | 5 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Exact Sciences Corporation | 4 | $64 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Amgen Inc. | 2 | $37 |
Products named: UBRELVY, NURTEC ODT, REXULTI, CAPLYTA, VRAYLAR, Auvelity, JARDIANCE, QULIPTA.
Industry payments across IN — which companies pay providers there.
